The Competition Commission of India (CCI) is inquiring into a matter for alleged violation of provisions of Section 3 and 4 of the Competition Act, 2002 relating to imposition of unfair prices by private super-specialty hospitals. Finding prima facie contravention of the provisions of the Act, the Commission referred the matter to the Director General (DG) for investigation. Pursuant to the aforesaid order of the Commission, the DG submitted the investigation report.
After perusing the material on record, the Commission noted that huge profit margins are being earned by the sale of products to the locked-in in-patients to the detriment of such patients. Considering the mandate given to the Commission to eliminate the practices having an adverse effect on competition and to protect the interest of consumers, the Commission decided to widen the scope of the investigation to cover the practices of super specialty hospitals across Delhi in respect of healthcare products and services provided to their in-patients.
Also Read: SC orders private hospitals to provide free treatment to poor
Investigation will focus on the products sold by the super specialty hospitals to their in-patients which are not required on an urgent basis for any medical procedure / intervention or which do not involve any high degree of quality issue from the medical procedure point of view and for the purchase of which the patients have the time and scope to exercise their rational choice to purchase such products from the open market where such products may be available at lower rates. The Commission has directed the DG to complete investigation expeditiously.
By broadening the scope of investigation in the matter, the Commission aims to prevent practices having an adverse effect on competition in the tertiary healthcare sector.
